Please login to the form below

Not currently logged in
Email:
Password:

RedoxTherapies

This page shows the latest RedoxTherapies news and features for those working in and with pharma, biotech and healthcare.

Juno cleared to restart CAR-T trial after deaths

Juno cleared to restart CAR-T trial after deaths

Buys RedoxTherapies. Meanwhile, Juno has added to its pipeline with a deal to acquire Boston-based biotech RedoxTherapies and lead compound vidapenant, a small-molecule adenosine 2A receptor antagonist that is ... The company is paying $10m upfront for

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Syneos Health™

Syneos Health™ is the only fully integrated biopharmaceutical solutions organization. Our company, including a Contract Research Organization (CRO) and Contract...

Latest intelligence

PM Society Digital Awards – the power of together
Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduction_feature_image_thumb.jpg
Seduce anyone in four simple steps
You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government
GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....

Infographics